MeSH Browser

MeSH Supplementary: fedratinib
Unique ID: C528327
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C528327
Entry Term(s): Inrebic; N-tert-butyl-3-((5-methyl-2-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)pyrimidin-4-yl)amino) benzenesulfonamide dihydrochloride monohydrate; N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino) pyrimidin-4-ylamino)benzenesulfonamide; SAR-302503; SAR-302503A; SAR302503; SAR302503A; TG-101348; TG101348; fedratinib dihydrochloride monohydrate; fedratinib hydrochloride; fedratinib hydrochloride monohydrate
Registry Numbers: 6L1XP550I6; 0; UH9J2HBQWJ
Related Numbers: UH9J2HBQWJ
Heading Mapped to: *Pyrrolidines; *Benzenesulfonamides
Frequency: 104
Note: a selective small-molecule inhibitor of JAK2
Source: Cancer Cell 2008 Apr;13(4):311-20
Date of Entry: 2008/04/24
Revision Date: 2023/06/22

Concept UI: M000757177
Registry Numbers: 0
Terms: SAR302503 Preferred Term
Term UI T820363
Date04/05/2012
LexicalTag LAB
ThesaurusID NLM (2012); SAR-302503
Term UI T001121300
Date06/10/2022
LexicalTag LAB
ThesaurusID; SAR-302503A
Term UI T001121301
Date06/10/2022
LexicalTag LAB
ThesaurusID NLM (2022); SAR302503A
Term UI T001121302
Date06/10/2022
LexicalTag LAB
ThesaurusID

fedratinib MeSH Supplementary Concept Data 2025